News Focus
News Focus
Followers 30
Posts 9830
Boards Moderated 0
Alias Born 12/15/2004

Re: Paulness post# 48029

Friday, 04/20/2007 12:44:16 PM

Friday, April 20, 2007 12:44:16 PM

Post# of 64738
Paulness: Show me any material put out by the company, in any SEC filing, any PR, or any of Malcolm's interviews where it was mentioned that they were working on a method to produce synthetic or enzymatically produced DNA. What happened was that the company realized (but didn't publicize) the fact that traditional fermented DNA was too expensive and made ssDNA and other DNA based therapeutics too expensive to be economically viable. First, the cost of product to test was too expensive. Second, even if approved the cost of the drug would be too expensive. Perhaps stumbled is a bit too harsh. But the development of synDNA was certainly the byproduct of economic necessity and a fortuitous example of scientific serendipity. And no, I haven't sold a single share (much to my chagrin) and still hold approximately $100 K worth of this company at current prices. And it would be no problem to accumulate this stock at current prices. I perceive no buying pressure in this stock at the present time. I'm more worried about a further drop in the share price, not about an inability to buy more shares. Sometimes I think your love affair with the company detracts from your abilities to think rationally.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today